Warren, Katherine E <br/><br/>
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.  [electronic resource] 

 -  Journal of neuro-oncology  Feb 2012 
 - 643-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-011-0709-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Agents--therapeutic use<br/>Brain Stem Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>DNA Modification Methylases--metabolism<br/>DNA Repair Enzymes--metabolism<br/>Dacarbazine--analogs & derivatives<br/>Drug Therapy, Combination--methods<br/>Female<br/>Glioma--drug therapy<br/>Guanine--analogs & derivatives<br/>Humans<br/>Kaplan-Meier Estimate<br/>Ki-67 Antigen--metabolism<br/>Male<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Temozolomide<br/>Tumor Suppressor Proteins--metabolism<br/>Young Adult